# Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma

> **NCT02264379** · — · COMPLETED · sponsor: **Technische Universität Dresden** · enrollment: 73 (actual)

## Conditions studied

- Oligometastatic Disease
- Prostate Cancer

## Interventions

- **RADIATION:** normal fractionated irradiation
- **RADIATION:** hypo fractionated irradiation

## Key facts

- **NCT ID:** NCT02264379
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2020-10
- **Final completion:** 2021-08
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02264379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02264379, "Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02264379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*